Skip to Content

SEC Filings

Filing date	Form	Description	View
Jul 12, 2013	FWP	FWP	0001104659-13-054126.pdf 0001104659-13-054126.rtf 0001104659-13-054126.xls View HTML
Jul 12, 2013	8-K	Report of unscheduled material events or corporate event	0001104659-13-054237.pdf 0001104659-13-054237.rtf 0001104659-13-054237.xls View HTML
Jul 12, 2013	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001047469-13-007538.pdf 0001047469-13-007538.rtf 0001047469-13-007538.xls View HTML
Jul 12, 2013	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001047469-13-007540.pdf 0001047469-13-007540.rtf 0001047469-13-007540.xls View HTML
Jul 10, 2013	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001047469-13-007472.pdf 0001047469-13-007472.rtf 0001047469-13-007472.xls View HTML
Jul 10, 2013	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001047469-13-007474.pdf 0001047469-13-007474.rtf 0001047469-13-007474.xls View HTML
Jul 10, 2013	8-K	Report of unscheduled material events or corporate event	0001104659-13-053869.pdf 0001104659-13-053869.rtf 0001104659-13-053869.xls View HTML
Jul 10, 2013	305B2	Initial statement filed pursuant to the Trust Indenture Act	0001104659-13-053870.pdf 0001104659-13-053870.rtf 0001104659-13-053870.xls View HTML
Jun 13, 2013	8-K	Report of unscheduled material events or corporate event	0001104659-13-048879.pdf 0001104659-13-048879.rtf 0001104659-13-048879.xls View HTML
Jun 13, 2013	4	Statement of changes in beneficial ownership of securities	0001179110-13-010325.pdf 0001179110-13-010325.rtf View HTML

Data provided by Kaleidoscope.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-720-8606
info@merrimack.com

© 2024 Merrimack Pharmaceuticals.